We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MS Drug

News List

MS drug could reduce painful side effects of common cancer treatment europeanpharmaceuticalreview
May 02, 2018
Researchers have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib…
Study Shows Biogen’s MS drug Tecfidera could make cancer-killing viruses more potent fiercebiotech
January 26, 2018
The Cancer-killing“oncolytic” viruses, which was derived from herpes, made their way into oncology practices in 2015 with Amgen’s melanoma drug Imlygic being approved.
Biogen reaches $1.25-billion settlement, licensing agreement with Forward Pharma in MS drug patent d firstwordpharma
January 18, 2017
Biogen announced Tuesday that it has agreed to enter a $1.25-billion settlement and licensing agreement with Forward Pharma under which it will obtain an irrevocable license to all of the latter's intellectual property.